Form 4 for MIRM Mirum Pharmaceuticals, Inc.

Accepted 2023-09-12 00:00:00 ET · period of report 2023-09-11 · accession 0001209191-23-049133 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-09-12	2023-09-11	MIRM	BJERKHOLT ERIC	CFO	P - Purchase	$29.65	+10.0K	10.0K	New	+$296.5K
DM	2023-09-12	2023-09-11	MIRM	BJERKHOLT ERIC	CFO	A - Grant	$0.00	+165.0K	55.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-09-11	P	A	10,000	$29.65	10,000	D	—	—	(F1) The price reported on this Form 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $29.61 to $29.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein.
2	Derivative	Stock Option (right to buy)	2023-09-11	A	A	110,000	$0.00	110,000	D	$30.43 · — to 2033-09-10	110,000 Common Stock	(F2) 1/4th of the shares subject to the Option will vest one year after September 11, 2023 (the "Vesting Commencement Date") and the balance of the shares will vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
3	Derivative	Restricted Stock Units	2023-09-11	A	A	55,000	$0.00	55,000	D	— · — to —	55,000 Common Stock	(F3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023.